V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 220005133 | 220002016 | 1.75 | 72.3 | Palliative (P) | 2016-04-11 | 2016-04-11 | Cytarabine Low Dose | N | N | 220027526 | CYTARABINE |
| 220005134 | 220015918 | null | 83 | Curative (C) | 2013-04-17 | 2013-04-23 | AML17 TRIAL | N | N | 220027534 | AML17 TRIAL |
| 220005135 | 220018722 | null | 78 | Not known (9) | 2014-10-21 | 2014-10-21 | AML17 TRIAL | N | N | 220027535 | AML17 TRIAL |
| 220005136 | 220020307 | 1.57 | 60.9 | Curative (C) | 2016-03-23 | 2016-03-23 | AML17 TRIAL | N | N | 220027538 | AML17 TRIAL |
| 220005137 | 220002017 | 1.67 | 73 | Palliative (P) | 2015-12-10 | 2015-12-11 | Trial Unspecified | Y | N | 220027543 | TRIAL |
| 220005138 | 220011067 | 1.59 | 76.2 | Curative (C) | 2014-11-14 | 2015-05-15 | AML17 TRIAL | N | N | 220027546 | AML17 TRIAL |
| 220005139 | 220011067 | 1.65 | 96.9 | null | 2013-01-07 | 2013-01-07 | AML17 TRIAL | Y | null | 220027546 | AML17 TRIAL |
| 220005140 | 220011067 | 1.82 | 70.8 | Palliative (P) | null | 2015-08-10 | CYTARABINE | null | null | 220027546 | CYTARABINE |
| 220005141 | 220011067 | 1.63 | null | Curative (C) | 2014-02-13 | 2014-02-23 | Trial Unspecified | N | N | 220027546 | TRIAL |
| 220005142 | 220011067 | 1.5 | 76 | Curative (C) | 2013-03-28 | 2013-03-28 | Trial Unspecified | 1 | N | 220027546 | TRIAL |
| 220005144 | 220002019 | 1.63 | 73.2 | Curative (C) | 2015-09-30 | 2015-09-30 | LI-1 TRIAL | Y | N | 220027553 | TRIAL |
| 220005145 | 220002019 | 1.52 | 80 | Curative (C) | 2017-03-20 | 2017-03-20 | AML17 TRIAL | Y | N | 220027553 | AML17 TRIAL |
| 220005146 | 220002020 | null | 147.9 | Palliative (P) | 2013-01-20 | 2013-01-20 | Cytarabine Low Dose | N | N | 220027555 | CYTARABINE |
| 220005147 | 220002020 | 1.61 | 77.7 | Curative (C) | 2013-03-06 | 2013-03-06 | Trial Unspecified | Y | N | 220027555 | TRIAL |
| 220005148 | 220002021 | 1.52 | 69.5 | null | 2013-01-21 | 2013-01-22 | AML17 TRIAL | 01 | N | 220027562 | AML17 TRIAL |
| 220005149 | 220002021 | 1.59 | 110.7 | Palliative (P) | null | 2017-06-29 | Cytarabine Low Dose | N | N | 220027562 | CYTARABINE |
| 220005150 | 220002021 | 1.56 | 84 | Curative (C) | 2013-04-28 | 2013-04-29 | Trial Unspecified | Y | N | 220027562 | TRIAL |
| 220005151 | 220002021 | 1.68 | 90 | Palliative (P) | 2015-07-27 | 2015-07-27 | Trial Unspecified | 01 | N | 220027562 | TRIAL |
| 220005152 | 220002021 | 1.78 | 74.5 | Disease modification (D) | null | 2013-03-18 | LI-1 TRIAL | N | N | 220027562 | TRIAL |
| 220005153 | 220002022 | null | 73.4 | Not known (9) | 2014-01-20 | 2014-01-20 | Cytarabine Low Dose | 02 | N | 220027577 | CYTARABINE |
| 220005154 | 220002022 | 1.8 | 66.4 | Palliative (P) | 2014-05-13 | 2014-05-14 | Trial Unspecified | 1 | N | 220027577 | TRIAL |
| 220005155 | 220002022 | 1.72 | 85 | null | 2013-05-31 | 2013-05-31 | Cytarabine low (10to20mg/m2) IV/SC | N | N | 220027577 | CYTARABINE |
| 220005156 | 220002022 | null | 69.5 | Curative (C) | 2014-06-26 | 2014-06-27 | AML17 TRIAL | 1 | N | 220027577 | AML17 TRIAL |
| 220005157 | 220002022 | 1.74 | null | Disease modification (D) | 2013-12-12 | 2013-12-13 | Cytarabine Low Dose | 2 | N | 220027577 | CYTARABINE |
| 220005158 | 220002022 | 0 | null | null | 2013-02-13 | 2013-02-24 | Cytarabine Low Dose | null | N | 220027577 | CYTARABINE |
| 220005159 | 220002023 | 1.73 | null | Curative (C) | 2015-01-31 | 2015-01-31 | Trial Unspecified | Y | N | 220027588 | TRIAL |
| 220005160 | 220011072 | 1.74 | null | null | 2017-12-06 | 2017-12-06 | CYTARABINE | 02 | N | 220027589 | CYTARABINE |
| 220005161 | 220011072 | 1.56 | 61 | Not known (9) | 2017-09-14 | 2017-09-20 | AML17 TRIAL | Y | N | 220027589 | AML17 TRIAL |
| 220005162 | 220002024 | null | 65 | Disease modification (D) | 2013-07-05 | 2013-07-06 | CYTARABINE | N | N | 220027591 | CYTARABINE |
| 220005163 | 220002024 | 1.62 | null | Curative (C) | 2013-09-11 | 2013-09-11 | AML17 TRIAL | 01 | N | 220027591 | AML17 TRIAL |
| 220005164 | 220002025 | null | 85.699 | Curative (C) | 2013-02-07 | 2013-02-07 | AML17 TRIAL | Y | N | 220027594 | AML17 TRIAL |
| 220005165 | 220002025 | 1.53 | 114.5 | Curative (C) | 2013-08-27 | 2013-09-06 | AML17 TRIAL | N | N | 220027594 | AML17 TRIAL |
| 220005166 | 220002025 | 1.68 | 73 | Curative (C) | 2016-11-15 | 2016-11-15 | Trial Unspecified | Y | N | 220027594 | TRIAL |
| 220005167 | 220002025 | 1.85 | null | Curative (C) | 2013-05-02 | 2013-05-02 | Trial Unspecified | 1 | N | 220027594 | TRIAL |
| 220005168 | 220002025 | 1.65 | 75 | Not known (9) | null | 2013-11-25 | Trial Unspecified | Y | N | 220027594 | TRIAL |
| 220005169 | 220002026 | null | 74.5 | Curative (C) | 2017-05-05 | 2017-05-06 | Trial Unspecified | Y | N | 220027601 | TRIAL |
| 220005170 | 220002026 | 1.57 | 76.2 | Palliative (P) | 2014-04-17 | 2014-05-27 | Cytarabine Low Dose | 02 | N | 220027601 | CYTARABINE |
| 220005171 | 220002026 | null | 76.4 | Curative (C) | 2013-10-22 | 2013-10-23 | Cytarabine low (10to20mg/m2) IV/SC | N | N | 220027601 | CYTARABINE |
| 220005172 | 220002026 | 1.71 | 90.8 | null | 2016-01-11 | 2016-01-11 | CYTARABINE | 2 | N | 220027601 | CYTARABINE |
| 220005173 | 220002027 | 1.63 | null | Palliative (P) | 2013-10-07 | 2013-10-07 | Cytarabine Low Dose | 2 | N | 220027609 | CYTARABINE |
| 220005174 | 220002028 | 1.83 | null | Palliative (P) | 2014-03-31 | 2014-04-01 | CYTARABINE | 2 | null | 220027611 | CYTARABINE |
| 220005175 | 220011076 | null | 78.2 | Curative (C) | 2016-10-07 | 2016-10-08 | Trial Unspecified | 1 | N | 220027612 | TRIAL |
| 220005176 | 220011076 | 1.82 | 0 | null | 2017-07-24 | 2017-07-24 | CYTARABINE | N | N | 220027612 | CYTARABINE |
| 220005177 | 220011076 | 1.49 | 66 | Curative (C) | 2014-05-21 | 2014-05-21 | Trial Unspecified | null | null | 220027612 | TRIAL |
| 220005185 | 220002030 | 1.55 | 93.3 | Palliative (P) | 2017-11-21 | 2017-11-21 | Cytarabine Low Dose | N | N | 220027629 | CYTARABINE |
| 220005186 | 220002030 | 1.78 | null | Not known (9) | 2014-06-09 | 2014-06-10 | AML17 TRIAL | 01 | null | 220027629 | AML17 TRIAL |
| 220005187 | 220002030 | 1.75 | 83 | Not known (9) | 2014-12-28 | 2015-01-08 | Trial Unspecified | Y | N | 220027629 | TRIAL |
| 220005189 | 220002032 | 1.55 | null | Palliative (P) | 2016-05-16 | 2016-07-18 | Cytarabine low (10to20mg/m2) IV/SC | 2 | null | 220027642 | CYTARABINE |
| 220005192 | 220002033 | 0 | null | Curative (C) | 2015-11-16 | 2015-11-17 | Cytarabine Low Dose | N | N | 220027648 | CYTARABINE |
| 220005193 | 220002033 | 1.63 | null | null | 2017-09-11 | 2017-09-14 | Cytarabine Low Dose | 02 | N | 220027648 | CYTARABINE |